At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DVA DaVita HealthCare Partners
Pre-Mkt 03-17 06:02:23 EDT
148.22
-2.50
-1.66%
High151.80Low147.76Vol1.04M
Open150.00D1 Closing150.72Amplitude2.68%
Mkt Cap9.90BTradable Cap5.22BTotal Shares66.80M
T/O155.61MT/O Rate2.95%Tradable Shares35.22M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

DaVita Inc. Stock Outperforms Competitors Despite Losses On The Day
Dow Jones  ·  03-13
DaVita Inc. Stock Outperforms Competitors Despite Losses On The Day
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  03-05
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
DaVita Inc. Stock Underperforms Monday When Compared To Competitors
Dow Jones  ·  03-03
DaVita Inc. Stock Underperforms Monday When Compared To Competitors
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  02-28
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
DaVita CFO Joel Ackerman and IR VP Nic Eliason to Join Fireside Chat at TD Cowen 46th Annual Health Care Conference
Reuters  ·  02-25
DaVita CFO Joel Ackerman and IR VP Nic Eliason to Join Fireside Chat at TD Cowen 46th Annual Health Care Conference
Three hurt working on Exxon Beaumont, Texas small CDU, sources say
Reuters  ·  02-14
Three hurt working on Exxon Beaumont, Texas small CDU, sources say
20 Stocks of Companies That Delivered a Double Dose of Growth This Earnings Season
Dow Jones  ·  02-12
20 Stocks of Companies That Delivered a Double Dose of Growth This Earnings Season
20 stocks of companies that delivered a double dose of growth this earnings season
Dow Jones  ·  02-12
20 stocks of companies that delivered a double dose of growth this earnings season
DaVita posts FY debt expense of USD 580 million, up 23.4%
Reuters  ·  02-12
DaVita posts FY debt expense of USD 580 million, up 23.4%
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  02-11
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Top Ten Scientific and Technological Innovations in Shandong for 2025 Announced
Deep News  ·  02-09
Top Ten Scientific and Technological Innovations in Shandong for 2025 Announced
A Look At DaVita (DVA) Valuation After 2025 Earnings And Share Buybacks
Simply Wall St.  ·  02-09
A Look At DaVita (DVA) Valuation After 2025 Earnings And Share Buybacks
DaVita Inc. Stock Underperforms Friday When Compared To Competitors
Dow Jones  ·  02-07
DaVita Inc. Stock Underperforms Friday When Compared To Competitors
BUZZ-US stocks weekly: Clawed
Reuters  ·  02-07
BUZZ-US stocks weekly: Clawed
Stock Track | DaVita HealthCare Partners Soars 5.05% Intraday After Truist Securities Raises Price Target
Stock Track  ·  02-06
Stock Track | DaVita HealthCare Partners Soars 5.05% Intraday After Truist Securities Raises Price Target
DaVita Inc : Truist Securities Raises Target Price to $158 From $128
THOMSON REUTERS  ·  02-05
DaVita Inc : Truist Securities Raises Target Price to $158 From $128
DaVita Is Maintained at Buy by UBS
Dow Jones  ·  02-05
DaVita Is Maintained at Buy by UBS
UBS Adjusts Price Target on DaVita to $190 From $186, Maintains Buy Rating
MT Newswires Live  ·  02-04
UBS Adjusts Price Target on DaVita to $190 From $186, Maintains Buy Rating
Stock Track | DaVita HealthCare Partners Soars 5.15% Intraday Following Analyst Target Price Increases
Stock Track  ·  02-04
Stock Track | DaVita HealthCare Partners Soars 5.15% Intraday Following Analyst Target Price Increases
Analysts Offer Insights on Healthcare Companies: DaVita (DVA) and Immunocore Holdings (IMCR)
TIPRANKS  ·  02-04
Analysts Offer Insights on Healthcare Companies: DaVita (DVA) and Immunocore Holdings (IMCR)

Introduction

Company Name.
DaVita HealthCare Partners
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Issue price:
--